99 related articles for article (PubMed ID: 15209875)
21. [Circulating endothelial microparticles: a new marker of vascular injury].
Boulanger CM; Leroyer AS; Amabile N; Tedgui A
Ann Cardiol Angeiol (Paris); 2008 Jun; 57(3):149-54. PubMed ID: 18579117
[TBL] [Abstract][Full Text] [Related]
22. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis.
Uchimura H; Marumo T; Takase O; Kawachi H; Shimizu F; Hayashi M; Saruta T; Hishikawa K; Fujita T
J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001
[TBL] [Abstract][Full Text] [Related]
23. Improvement of endothelial function by systemic transfusion of vascular progenitor cells.
Wassmann S; Werner N; Czech T; Nickenig G
Circ Res; 2006 Oct; 99(8):e74-83. PubMed ID: 16990568
[TBL] [Abstract][Full Text] [Related]
24. Relationship between vascular damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 expression in the bone marrow.
Foresta C; Caretta N; Lana A; De Toni L; Biagioli A; Vinanzi C; Ferlin A
Eur Urol; 2007 May; 51(5):1411-7; discussion 1417-9. PubMed ID: 17034932
[TBL] [Abstract][Full Text] [Related]
25. Endothelial progenitor cells as a new agent contributing to vascular repair.
Miller-Kasprzak E; Jagodziński PP
Arch Immunol Ther Exp (Warsz); 2007; 55(4):247-59. PubMed ID: 17659378
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization.
Goukassian DA; Qin G; Dolan C; Murayama T; Silver M; Curry C; Eaton E; Luedemann C; Ma H; Asahara T; Zak V; Mehta S; Burg A; Thorne T; Kishore R; Losordo DW
Circulation; 2007 Feb; 115(6):752-62. PubMed ID: 17261656
[TBL] [Abstract][Full Text] [Related]
27. Endothelium-derived microparticles inhibit human cardiac valve endothelial cell function.
Klinkner DB; Densmore JC; Kaul S; Noll L; Lim HJ; Weihrauch D; Pritchard KA; Oldham KT; Sander TL
Shock; 2006 Jun; 25(6):575-80. PubMed ID: 16721264
[TBL] [Abstract][Full Text] [Related]
28. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity.
Avouac J; Juin F; Wipff J; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
Ann Rheum Dis; 2008 Oct; 67(10):1455-60. PubMed ID: 18174219
[TBL] [Abstract][Full Text] [Related]
29. Endothelial progenitor cells in patients with essential hypertension.
Delva P; Degan M; Vallerio P; Arosio E; Minuz P; Amen G; Di Chio M; Lechi A
J Hypertens; 2007 Jan; 25(1):127-32. PubMed ID: 17143183
[TBL] [Abstract][Full Text] [Related]
30. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice.
Foteinos G; Hu Y; Xiao Q; Metzler B; Xu Q
Circulation; 2008 Apr; 117(14):1856-63. PubMed ID: 18378610
[TBL] [Abstract][Full Text] [Related]
31. Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease.
Baumhäkel M; Werner N; Böhm M; Nickenig G
Eur Heart J; 2006 Sep; 27(18):2184-8. PubMed ID: 16926179
[TBL] [Abstract][Full Text] [Related]
32. Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease.
Liguori A; Fiorito C; Balestrieri ML; Crimi E; Bruzzese G; Williams-Ignarro S; D'Amora M; Sommese L; Grimaldi V; Minucci PB; Giovane A; Farzati B; Ignarro LJ; Napoli C
Eur J Haematol; 2008 Mar; 80(3):258-64. PubMed ID: 18081701
[TBL] [Abstract][Full Text] [Related]
33. Characteristics and function of cryopreserved bone marrow-derived endothelial progenitor cells.
Mieno S; Clements RT; Boodhwani M; Sodha NR; Ramlawi B; Bianchi C; Sellke FW
Ann Thorac Surg; 2008 Apr; 85(4):1361-6. PubMed ID: 18355528
[TBL] [Abstract][Full Text] [Related]
34. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors.
Voghel G; Thorin-Trescases N; Farhat N; Nguyen A; Villeneuve L; Mamarbachi AM; Fortier A; Perrault LP; Carrier M; Thorin E
Mech Ageing Dev; 2007; 128(11-12):662-71. PubMed ID: 18022214
[TBL] [Abstract][Full Text] [Related]
35. Circulating endothelial progenitor cells in cardiovascular disorders.
Geft D; Schwartzenberg S; George J
Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1115-21. PubMed ID: 18793114
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of the interaction between circulating and in vitro cultivated endothelial progenitor cells and the endothelial barrier.
Funcke F; Hoyer H; Brenig F; Steingen C; Ladage D; Müller-Ehmsen J; Schmidt A; Brixius K; Bloch W
Eur J Cell Biol; 2008 Feb; 87(2):81-90. PubMed ID: 17945378
[TBL] [Abstract][Full Text] [Related]
37. Pathological aging of the vascular endothelium: are endothelial progenitor cells the sentinels of the cardiovascular system?
Thorin-Trescases N; Voghel G; Gendron ME; Krummen S; Farhat N; Drouin A; Perrault LP; Thorin E
Can J Cardiol; 2005 Oct; 21(12):1019-24. PubMed ID: 16234883
[TBL] [Abstract][Full Text] [Related]
38. The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris.
Barsheshet A; Hod H; Shechter M; Sharabani-Yosef O; Rosenthal E; Barbash IM; Matetzky S; Tal R; Bentancur AG; Sela BA; Nagler A; Leor J
Cardiology; 2008; 110(3):160-6. PubMed ID: 18057883
[TBL] [Abstract][Full Text] [Related]
39. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure.
Valgimigli M; Rigolin GM; Fucili A; Porta MD; Soukhomovskaia O; Malagutti P; Bugli AM; Bragotti LZ; Francolini G; Mauro E; Castoldi G; Ferrari R
Circulation; 2004 Sep; 110(10):1209-12. PubMed ID: 15249502
[TBL] [Abstract][Full Text] [Related]
40. Potent inhibitory effect of sirolimus on circulating vascular progenitor cells.
Fukuda D; Sata M; Tanaka K; Nagai R
Circulation; 2005 Feb; 111(7):926-31. PubMed ID: 15710768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
